The combination of a RAAS inhibitor with a steroidal MRA (spironolactone or eplerenone) may not be suitable, despite steroidal MRAs demonstrating efficacy in conditions such as HFrEF, resistant hypertension [58,59,60,61], hyperaldosteronism (spironolactone), as well as reducing proteinuria/albuminuria [60,61,62,63]
By unlocking the microbial and molecular signals that drive GLP-1 activity, we empower you to feel fuller, balance blood sugar, and optimize metabolic wellnessnaturally
These treatments are highly effective at helping patients lose weight by controlling appetite, regulating blood sugar, and supporting sustainable lifestyle changes
As the GLP-1 landscape grows more complex with oral and injectable options, varying doses, and emerging maintenance therapies, employers are asking Omada to help navigate it all